tiprankstipranks
Advertisement
Advertisement

ARWR Stock Latest News

Arrowhead Pharmaceuticals Adds Experienced Healthcare Investor to Board
Company AnnouncementsArrowhead Pharmaceuticals Adds Experienced Healthcare Investor to Board
4d ago
8K
ARWR
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
PremiumTipRanks Newswire
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
19d ago
NVO
ARWR
Arrowhead’s Inhaled ARO-RAGE Asthma Trial Enters Active Recruitment, Keeping a Key Pipeline Catalyst in Play
PremiumCompany Announcements
Arrowhead’s Inhaled ARO-RAGE Asthma Trial Enters Active Recruitment, Keeping a Key Pipeline Catalyst in Play
23d ago
ARWR
Arrowhead Pharmaceuticals: Buy Rating Reaffirmed as ARO-INHBE Data Strengthen Outlook and $100 Price Target Maintained
PremiumRatings
Arrowhead Pharmaceuticals: Buy Rating Reaffirmed as ARO-INHBE Data Strengthen Outlook and $100 Price Target Maintained
24d ago
ARWR
Arrowhead presents interim results from Phase 1/2a trial of ARO-INHBE
PremiumThe Fly
Arrowhead presents interim results from Phase 1/2a trial of ARO-INHBE
24d ago
ARWR
Arrowhead presents clinical cardiometabolic data at EAS Congress
PremiumThe FlyArrowhead presents clinical cardiometabolic data at EAS Congress
25d ago
ARWR
Arrowhead’s ARO-C3 Kidney Trial Reaches Completion, Setting Up the Next Catalyst for ARWR Investors
Premium
Company Announcements
Arrowhead’s ARO-C3 Kidney Trial Reaches Completion, Setting Up the Next Catalyst for ARWR Investors
29d ago
ARWR
Arrowhead’s ARO-CFB Kidney Trial Completion: What Investors Should Watch Next
Premium
Company Announcements
Arrowhead’s ARO-CFB Kidney Trial Completion: What Investors Should Watch Next
1M ago
ARWR
Arrowhead price target raised to $46 from $35 at Bernstein
PremiumThe Fly
Arrowhead price target raised to $46 from $35 at Bernstein
1M ago
ARWR
Arrowhead Pharmaceuticals’ Earnings Call: Launch, Losses, Bets
PremiumCompany Announcements
Arrowhead Pharmaceuticals’ Earnings Call: Launch, Losses, Bets
1M ago
ARWR
Arrowhead price target raised to $90 from $80 at Chardan
PremiumThe Fly
Arrowhead price target raised to $90 from $80 at Chardan
1M ago
ARWR
Arrowhead reports Q2 EPS (93c), consensus ($1.11)
PremiumThe Fly
Arrowhead reports Q2 EPS (93c), consensus ($1.11)
1M ago
ARWR
Arrowhead announces exclusive worldwide license agreement with Madrigal Pharma
PremiumThe FlyArrowhead announces exclusive worldwide license agreement with Madrigal Pharma
2M ago
ARWR
MDGL
Is ARWR a Buy, Before Earnings?
Premium
Pre-Earnings
Is ARWR a Buy, Before Earnings?
2M ago
ARWR
Arrowhead announces Australian TGA approved Redemplo for FCS
Premium
The Fly
Arrowhead announces Australian TGA approved Redemplo for FCS
2M ago
ARWR
Arrowhead initiated with an Overweight at JPMorgan
PremiumThe Fly
Arrowhead initiated with an Overweight at JPMorgan
2M ago
ARWR
Arrowhead, Astera, Exxon, Intel, Halliburton Trending With Analysts
PremiumWeekend Updates
Arrowhead, Astera, Exxon, Intel, Halliburton Trending With Analysts
2M ago
HAL
XOM
Arrowhead announces EMA recommended approval of Redemplo
PremiumThe Fly
Arrowhead announces EMA recommended approval of Redemplo
2M ago
ARWR
Intel upgraded, Reddit initiated: Wall Street’s top analyst calls
PremiumThe Fly
Intel upgraded, Reddit initiated: Wall Street’s top analyst calls
2M ago
CL
MHK
Arrowhead upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe FlyArrowhead upgraded to Overweight from Equal Weight at Morgan Stanley
2M ago
ARWR
Arrowhead price target raised to $93 from $81 at BofA
Premium
The Fly
Arrowhead price target raised to $93 from $81 at BofA
2M ago
ARWR
Arrowhead presents long-term efficacy, safety data for plozasiran
Premium
The Fly
Arrowhead presents long-term efficacy, safety data for plozasiran
3M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >